Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120

The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 115; no. 10; pp. 2443 - 2448
Main Authors Yolitz, Jason, Schwing, Catherine, Chang, Julia, Van Ryk, Donald, Nawaz, Fatima, Wei, Danlan, Cicala, Claudia, Arthos, James, Fauci, Anthony S.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 06.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure.
AbstractList The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure.The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure.
The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure.
Significant heterogeneity exists in the structure and antigenicity of HIV-1 envelope protein (Env) gp120 due, in part, to various posttranslational modifications. Using glycan and antigenic analysis, we show that the signal peptide (SP) of HIV Env can impact the glycan profile of gp120, which in turn impacts antigenicity of the mature protein. Thus, although the SP is not present in the mature gp120 protein, it is likely subject to immune pressure. Moreover, to the extent that glycan content impacts transmission fitness, variation in the SP may influence transmission. These observations potentially help us better understand both the early events in HIV transmission as well as the mechanisms whereby HIV evades humoral immune responses, providing additional information for HIV vaccine design. The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure.
Author Yolitz, Jason
Cicala, Claudia
Chang, Julia
Nawaz, Fatima
Wei, Danlan
Van Ryk, Donald
Fauci, Anthony S.
Schwing, Catherine
Arthos, James
Author_xml – sequence: 1
  givenname: Jason
  surname: Yolitz
  fullname: Yolitz, Jason
  organization: National Institutes of Health–Johns Hopkins University Graduate Partnership Program, National Institutes of Health, Bethesda, MD 20892
– sequence: 2
  givenname: Catherine
  surname: Schwing
  fullname: Schwing, Catherine
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
– sequence: 3
  givenname: Julia
  surname: Chang
  fullname: Chang, Julia
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
– sequence: 4
  givenname: Donald
  surname: Van Ryk
  fullname: Van Ryk, Donald
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
– sequence: 5
  givenname: Fatima
  surname: Nawaz
  fullname: Nawaz, Fatima
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
– sequence: 6
  givenname: Danlan
  surname: Wei
  fullname: Wei, Danlan
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
– sequence: 7
  givenname: Claudia
  surname: Cicala
  fullname: Cicala, Claudia
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
– sequence: 8
  givenname: James
  surname: Arthos
  fullname: Arthos, James
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
– sequence: 9
  givenname: Anthony S.
  surname: Fauci
  fullname: Fauci, Anthony S.
  organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29463753$$D View this record in MEDLINE/PubMed
BookMark eNp9kbFv1DAYxS1URK8HMxMoEkuXtJ8dO7YXpKqitFIlBqCr5Thfgk85O8S-Svffk3ClhQ4Mlge_9_T8eyfkKMSAhLylcEZBVudjsOmMSsZqJikVL8iKgqZlzTUckRUAk6XijB-Tk5Q2AKCFglfkmGleV1JUK3L31ffBDsWIY_YtFrErrm_uCgz3OMQRi3GKGX0o_Ha0LqeiH_Yupv1gs4-hsKGdT_Y9Bu983i_2fqQMXpOXnR0Svnm41-T71advl9fl7ZfPN5cXt6UToHPpwLa11AANl3XNWym0oqKpLe2YQskcdw1tra46zrGBrlOq6VAzxK6iDlm1Jh8PueOu2WLrMOTJDmac_NZOexOtN_--BP_D9PHeCCWllvUccPoQMMWfO0zZbH1yOAw2YNwlwwBmsJWcYa_Jh2fSTdxNM7xFxRgFxfUS-P7vRo9V_iCfBecHgZtiShN2jxIKZhnVLKOap1Fnh3jmmFn_HmD-kh_-43t38G1SjtNTk1qAVEJVvwDpFrDD
CitedBy_id crossref_primary_10_1002_mco2_261
crossref_primary_10_3389_fimmu_2024_1476924
crossref_primary_10_3390_cells9071584
crossref_primary_10_3390_v14081729
crossref_primary_10_1038_s41467_021_21402_1
crossref_primary_10_1128_JVI_02221_20
crossref_primary_10_3390_v14081746
crossref_primary_10_1002_JLB_4MR0120_208R
crossref_primary_10_1016_j_jmb_2019_04_016
crossref_primary_10_1186_s13578_022_00809_3
crossref_primary_10_3390_vaccines9020176
crossref_primary_10_1016_j_talanta_2019_120551
crossref_primary_10_1016_j_biotechadv_2023_108283
crossref_primary_10_3390_v14030478
crossref_primary_10_1371_journal_ppat_1008476
crossref_primary_10_1016_j_isci_2019_10_030
crossref_primary_10_1016_j_vaccine_2018_03_091
crossref_primary_10_3389_fimmu_2023_1143034
crossref_primary_10_1016_j_vaccine_2018_09_056
crossref_primary_10_1016_j_jmb_2021_167332
crossref_primary_10_1016_j_vaccine_2023_09_059
crossref_primary_10_3390_v15020274
crossref_primary_10_1016_j_pep_2021_106013
crossref_primary_10_1089_aid_2018_0102
crossref_primary_10_3390_v11111012
crossref_primary_10_3390_cancers12113101
crossref_primary_10_1016_j_alcohol_2021_04_003
crossref_primary_10_3390_microorganisms8050624
crossref_primary_10_3390_v14050853
crossref_primary_10_1042_BSR20211930
crossref_primary_10_3390_vaccines13020148
crossref_primary_10_1097_QAD_0000000000002690
crossref_primary_10_1016_j_virol_2024_110147
crossref_primary_10_1371_journal_ppat_1009185
Cites_doi 10.1128/JVI.79.10.6528-6531.2005
10.1016/S0140-6736(00)04331-2
10.1189/jlb.0503208
10.1126/science.1066371
10.1073/pnas.89.21.10247
10.1006/viro.1994.1531
10.1038/nature10373
10.1128/JVI.00171-11
10.1128/JVI.05053-11
10.1097/COH.0b013e32832d9fef
10.1128/jvi.67.1.584-588.1993
10.1111/j.1432-1033.1981.tb06300.x
10.1016/S0092-8674(00)80694-7
10.1128/JVI.02108-09
10.1126/science.1093137
10.1093/bmb/58.1.19
10.1084/jem.20042510
10.1101/cshperspect.a006866
10.1016/S1074-7613(02)00259-5
10.1073/pnas.1304288110
10.1016/S0021-9258(18)86956-3
10.1016/j.febslet.2006.05.070
10.1096/fj.02-0811com
10.1038/nri3516
10.1006/viro.2000.0357
10.1093/glycob/cwh106
10.1128/jvi.67.12.7383-7393.1993
10.1126/science.1178746
10.1016/S0021-9258(18)37849-9
10.1126/science.1084238
10.1128/jvi.70.2.1100-1108.1996
10.1128/JVI.00105-10
10.1074/jbc.M104565200
10.1128/JVI.76.14.7306-7321.2002
10.2174/157016207782418560
10.1128/JVI.77.2.1337-1346.2003
10.1073/pnas.0911796106
10.1128/JVI.02132-08
10.1371/journal.ppat.1002209
10.1128/JVI.72.6.4694-4703.1998
10.1111/febs.13530
10.1128/jvi.67.7.3978-3988.1993
10.1111/j.1399-3054.1988.tb09192.x
10.1371/journal.pone.0023673
10.1086/429411
10.1016/S0962-8924(98)01360-9
10.1073/pnas.93.18.9606
10.1128/JVI.02164-14
10.1073/pnas.0802203105
10.1128/JVI.03235-14
10.7554/eLife.26067
10.1128/JVI.79.9.5762-5773.2005
10.1038/nri1960
10.1038/nature01470
10.1097/COH.0b013e3282f2982c
ContentType Journal Article
Copyright Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles
Copyright © 2018 the Author(s). Published by PNAS.
Copyright National Academy of Sciences Mar 6, 2018
Copyright © 2018 the Author(s). Published by PNAS. 2018
Copyright_xml – notice: Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles
– notice: Copyright © 2018 the Author(s). Published by PNAS.
– notice: Copyright National Academy of Sciences Mar 6, 2018
– notice: Copyright © 2018 the Author(s). Published by PNAS. 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
DOI 10.1073/pnas.1722627115
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
Ecology Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Entomology Abstracts
Genetics Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Virology and AIDS Abstracts
MEDLINE


CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1091-6490
EndPage 2448
ExternalDocumentID PMC5877976
29463753
10_1073_pnas_1722627115
26507858
Genre Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: Intramural NIH HHS
  grantid: Z01 AI000883
– fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
  grantid: AI000883-11
GroupedDBID ---
-DZ
-~X
.55
0R~
123
29P
2AX
2FS
2WC
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACHIC
ACIWK
ACNCT
ACPRK
ADQXQ
ADULT
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
BKOMP
CS3
D0L
DCCCD
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HH5
HYE
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
KQ8
L7B
LU7
N9A
N~3
O9-
OK1
PNE
PQQKQ
R.V
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
W8F
WH7
WOQ
WOW
X7M
XSW
Y6R
YBH
YKV
YSK
ZCA
~02
~KM
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c509t-c0ad67900b47664d759815b6a1f28e72c4cb1da93f44eb0ff88bfe92eef31ce23
ISSN 0027-8424
1091-6490
IngestDate Thu Aug 21 18:08:30 EDT 2025
Fri Jul 11 05:07:51 EDT 2025
Mon Jun 30 08:35:47 EDT 2025
Sat May 31 02:08:42 EDT 2025
Tue Jul 01 03:19:46 EDT 2025
Thu Apr 24 23:01:12 EDT 2025
Fri May 30 11:17:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords signal peptide
antigenicity
gp120
vaccine
HIV
Language English
License Copyright © 2018 the Author(s). Published by PNAS.
This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c509t-c0ad67900b47664d759815b6a1f28e72c4cb1da93f44eb0ff88bfe92eef31ce23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Contributed by Anthony S. Fauci, January 29, 2018 (sent for review January 2, 2018; reviewed by Mirko Paiardini and Guido Poli)
Reviewers: M.P., Emory Vaccine Center, Yerkes National Primate Research Center; and G.P., San Raffaele Scientific Institute.
Author contributions: J.Y., C.C., J.A., and A.S.F. designed research; J.Y., C.S., J.C., D.V.R., F.N., and D.W. performed research; D.V.R. contributed new reagents/analytic tools; J.Y., D.V.R., F.N., C.C., J.A., and A.S.F. analyzed data; and J.Y., C.C., J.A., and A.S.F. wrote the paper.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5877976
PMID 29463753
PQID 2022108496
PQPubID 42026
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5877976
proquest_miscellaneous_2007113707
proquest_journals_2022108496
pubmed_primary_29463753
crossref_primary_10_1073_pnas_1722627115
crossref_citationtrail_10_1073_pnas_1722627115
jstor_primary_26507858
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-03-06
PublicationDateYYYYMMDD 2018-03-06
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-06
  day: 06
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 2018
Publisher National Academy of Sciences
Publisher_xml – name: National Academy of Sciences
References e_1_3_3_50_2
e_1_3_3_16_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_56_2
e_1_3_3_33_2
e_1_3_3_54_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_52_2
e_1_3_3_40_2
e_1_3_3_5_2
e_1_3_3_7_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_23_2
e_1_3_3_48_2
e_1_3_3_25_2
e_1_3_3_46_2
e_1_3_3_1_2
e_1_3_3_44_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
e_1_3_3_51_2
e_1_3_3_17_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_32_2
e_1_3_3_55_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_53_2
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_28_2
e_1_3_3_49_2
Kapp K (e_1_3_3_20_2) 2009
e_1_3_3_24_2
e_1_3_3_47_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_2_2
e_1_3_3_43_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
References_xml – ident: e_1_3_3_13_2
  doi: 10.1128/JVI.79.10.6528-6531.2005
– ident: e_1_3_3_1_2
  doi: 10.1016/S0140-6736(00)04331-2
– ident: e_1_3_3_35_2
  doi: 10.1189/jlb.0503208
– ident: e_1_3_3_41_2
  doi: 10.1126/science.1066371
– ident: e_1_3_3_7_2
  doi: 10.1073/pnas.89.21.10247
– ident: e_1_3_3_23_2
  doi: 10.1006/viro.1994.1531
– ident: e_1_3_3_29_2
  doi: 10.1038/nature10373
– ident: e_1_3_3_48_2
  doi: 10.1128/JVI.00171-11
– ident: e_1_3_3_14_2
  doi: 10.1128/JVI.05053-11
– ident: e_1_3_3_6_2
  doi: 10.1097/COH.0b013e32832d9fef
– ident: e_1_3_3_21_2
  doi: 10.1128/jvi.67.1.584-588.1993
– ident: e_1_3_3_28_2
  doi: 10.1111/j.1432-1033.1981.tb06300.x
– ident: e_1_3_3_36_2
  doi: 10.1016/S0092-8674(00)80694-7
– ident: e_1_3_3_54_2
  doi: 10.1128/JVI.02108-09
– ident: e_1_3_3_12_2
  doi: 10.1126/science.1093137
– ident: e_1_3_3_10_2
  doi: 10.1093/bmb/58.1.19
– ident: e_1_3_3_43_2
  doi: 10.1084/jem.20042510
– ident: e_1_3_3_52_2
  doi: 10.1101/cshperspect.a006866
– ident: e_1_3_3_38_2
  doi: 10.1016/S1074-7613(02)00259-5
– ident: e_1_3_3_15_2
  doi: 10.1073/pnas.1304288110
– ident: e_1_3_3_8_2
  doi: 10.1016/S0021-9258(18)86956-3
– ident: e_1_3_3_51_2
  doi: 10.1016/j.febslet.2006.05.070
– ident: e_1_3_3_18_2
  doi: 10.1096/fj.02-0811com
– ident: e_1_3_3_55_2
  doi: 10.1038/nri3516
– ident: e_1_3_3_25_2
  doi: 10.1006/viro.2000.0357
– ident: e_1_3_3_9_2
  doi: 10.1093/glycob/cwh106
– ident: e_1_3_3_46_2
  doi: 10.1128/jvi.67.12.7383-7393.1993
– ident: e_1_3_3_31_2
  doi: 10.1126/science.1178746
– ident: e_1_3_3_49_2
  doi: 10.1016/S0021-9258(18)37849-9
– ident: e_1_3_3_53_2
  doi: 10.1126/science.1084238
– ident: e_1_3_3_30_2
  doi: 10.1128/jvi.70.2.1100-1108.1996
– ident: e_1_3_3_22_2
  doi: 10.1128/JVI.00105-10
– ident: e_1_3_3_40_2
  doi: 10.1074/jbc.M104565200
– ident: e_1_3_3_33_2
  doi: 10.1128/JVI.76.14.7306-7321.2002
– ident: e_1_3_3_45_2
  doi: 10.2174/157016207782418560
– ident: e_1_3_3_39_2
  doi: 10.1128/JVI.77.2.1337-1346.2003
– ident: e_1_3_3_56_2
  doi: 10.1073/pnas.0911796106
– ident: e_1_3_3_4_2
  doi: 10.1128/JVI.02132-08
– ident: e_1_3_3_16_2
  doi: 10.1371/journal.ppat.1002209
– ident: e_1_3_3_47_2
  doi: 10.1128/JVI.72.6.4694-4703.1998
– ident: e_1_3_3_32_2
  doi: 10.1111/febs.13530
– ident: e_1_3_3_44_2
  doi: 10.1128/jvi.67.7.3978-3988.1993
– ident: e_1_3_3_27_2
  doi: 10.1111/j.1399-3054.1988.tb09192.x
– ident: e_1_3_3_11_2
  doi: 10.1371/journal.pone.0023673
– ident: e_1_3_3_2_2
  doi: 10.1086/429411
– ident: e_1_3_3_19_2
  doi: 10.1016/S0962-8924(98)01360-9
– start-page: 1
  volume-title: Protein Transport into the Endoplasmic Reticulum
  year: 2009
  ident: e_1_3_3_20_2
– ident: e_1_3_3_24_2
  doi: 10.1073/pnas.93.18.9606
– ident: e_1_3_3_42_2
  doi: 10.1128/JVI.02164-14
– ident: e_1_3_3_3_2
  doi: 10.1073/pnas.0802203105
– ident: e_1_3_3_17_2
  doi: 10.1128/JVI.03235-14
– ident: e_1_3_3_26_2
  doi: 10.7554/eLife.26067
– ident: e_1_3_3_37_2
  doi: 10.1128/JVI.79.9.5762-5773.2005
– ident: e_1_3_3_34_2
  doi: 10.1038/nri1960
– ident: e_1_3_3_50_2
  doi: 10.1038/nature01470
– ident: e_1_3_3_5_2
  doi: 10.1097/COH.0b013e3282f2982c
SSID ssj0009580
Score 2.430518
Snippet The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of...
Significant heterogeneity exists in the structure and antigenicity of HIV-1 envelope protein (Env) gp120 due, in part, to various posttranslational...
SourceID pubmedcentral
proquest
pubmed
crossref
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2443
SubjectTerms Affinity
Amino acids
Antibodies, Monoclonal - metabolism
Antigenicity
Biological Sciences
CD4 antigen
DC-SIGN protein
Dendritic Cells
Disease transmission
Fitness
Glycan
Glycoprotein gp120
Glycosylation
HIV
HIV Envelope Protein gp120 - chemistry
HIV Envelope Protein gp120 - genetics
HIV Envelope Protein gp120 - immunology
HIV Envelope Protein gp120 - metabolism
HIV-1 - immunology
Human immunodeficiency virus
Monoclonal antibodies
Mucosa
Peptides
Protein Sorting Signals - genetics
Recombinant Fusion Proteins - chemistry
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - immunology
Recombinant Fusion Proteins - metabolism
Replication
Surface plasmon resonance
Viral envelope proteins
Title Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120
URI https://www.jstor.org/stable/26507858
https://www.ncbi.nlm.nih.gov/pubmed/29463753
https://www.proquest.com/docview/2022108496
https://www.proquest.com/docview/2007113707
https://pubmed.ncbi.nlm.nih.gov/PMC5877976
Volume 115
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKeOEFMWAQNpCReBiqUvLh2MnjhDZNaJRJa6fyFMWO3VVUaUVaTd1fv3PsfHQUafASVY7jVL6fL3f27-4Q-qQozbmnAtfjLHOJiDK9pKSbhHksWKSUkjrA-fuQno_Jt0k06fVuu9ElKz4QdzvjSv5HqtAGctVRsv8g2WZQaIDfIF-4goTh-igZX82m2phcamZKbvbkwZuTRcUD0hFQC13L0kZClv3pfCMW5caw32yW1pXOxjkTlpgxXfqB17VXL5vvW1mzCYb19uFJG4xiNUTZd_uXw7a08U9NrrszZNyyPe-_Eje3tpRKE4DYoRlYjvB6Pms-Gdf6oGHzy1j8ejO7u1nhV9F7Hu3oVzBPXEpMhdCB3NFWK2UT5Fmjz-vqWGISO_2h_EFb6YrFRVYOwCwLaMDqUbbSbA9_pGfji4t0dDoZPUFPA_Avwnqbp8nWHJs0Fvaf1TmhWPjlwfBb5oxhtO7yVR5Sbjs2zOgFem6dD3xikLSPerJ4ifZr4eFjm4P88yt0baCFLbTwQmGAFq6hhS20sIUW3oIWBmjhLrT04xW0XqPx2eno67lrS3C4AizJlSu8LKcs8TxOGKUkZ1ES-xGnma-CWLJAEMH9PEtCRYiENa_imCuZBFKq0BcyCA_QXrEo5FuEc6J0ERLOlJ-RmEdZBGMzJTwVMi4Jd9CgnslU2Pz0ukzKPK14EixM9dSn7dQ76Lh5YGlSs_y960ElmqZfAI4Ji6PYQUe1rFK7sMs0ALvW92KSUAd9bG6D2tVnaVkhF2vdB2xzP2Qec9AbI9p28ITQkEWhg9iW0JsOOqX79p1idlOldo9ixsBBePeI9x6iZ-0KO0J7q99r-R4M5BX_UIH5Hvk3vrQ
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Signal+peptide+of+HIV+envelope+protein+impacts+glycosylation+and+antigenicity+of+gp120&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Yolitz%2C+Jason&rft.au=Schwing%2C+Catherine&rft.au=Chang%2C+Julia&rft.au=Van+Ryk%2C+Donald&rft.date=2018-03-06&rft.issn=1091-6490&rft.eissn=1091-6490&rft.volume=115&rft.issue=10&rft.spage=2443&rft_id=info:doi/10.1073%2Fpnas.1722627115&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8424&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8424&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8424&client=summon